Valeant announces antitrust clearance for acquisition of Synergetics USA
Valeant announced termination of the waiting period under the Hart-Scott-Rodino Antitrust Act with respect to the previously announced tender offer for all of the outstanding shares of common stock of Synergetics USA at a price per share of $6.50, net to the holder in cash. October 05, 2015